They are/were very B2B focused, atleast in the past. Most of the volumes are from small mom and pop labs that outsource not so easy tests to Thyrocare. Samples are collected by small lab in area on same day and shipped to larger processing lab(Mumbai in my case) by flight. Generally results are available the next morning or so. However, because of the pandemic Thyrocare has had to go more direct(because volumes that small labs would process have fallen off a cliff), which I felt was lacking(very poor online channel and CEO who was brought in to fix this exited). I sold recently just before this deal was announced to my misfortune for that same reason and because of valuations ex- Covid. PharmEasy deal should fix that issue.